Patents Assigned to The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center
-
Patent number: 11944644Abstract: The present invention provides T-cells expressing at least two different chimeric antigen receptors, wherein one of the CARs binds specifically to CD138 and another CAR binds specifically to CD38. In particular, the present invention provides T-cells expressing two different CARs, when one CAR comprises anti-CD138 sc Fv and the second CAR anti-CD138 sc Fv. Further, the invention provides a pharmaceutical composition comprising these dual CAR T-cells and their use in treatment of cancer, in particular multiple myeloma, and methods for preparation of these cells.Type: GrantFiled: December 4, 2018Date of Patent: April 2, 2024Assignees: THE MEDICAL RESEARCH INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER, YEDA RESEARCH AND DEVELOPMENT CO. LTDInventors: Zelig Eshhar, Tova Waks, Anat Globerson Levin, Moran Rawet Slobodkin
-
Patent number: 11932871Abstract: Methods of culturing T cells are provided. Accordingly there is provided a method of culturing T cells comprising culturing T cells in the presence of a T cell stimulator, an exogenous CCL21 and an exogenous ICAM1, thereby culturing the T cells. Also provided are cell cultures, isolated T cells and uses of same.Type: GrantFiled: March 2, 2018Date of Patent: March 19, 2024Assignees: YEDA RESEARCH AND DEVELOPMENT CO. LTD., THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Benjamin Geiger, Nir Friedman, Shimrit Lieber, Zelig Eshhar, Tova Waks, Anat Globerson Levin
-
Patent number: 11891627Abstract: Provided is an apparatus and process for isolation of stromal vascular fraction (SVF) following lipoaspiration.Type: GrantFiled: June 9, 2016Date of Patent: February 6, 2024Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE, AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Nir Shani, Eyal Gur, Inna Solodeev, Anna Aronovich
-
Patent number: 11844602Abstract: A diagnostic system includes an array of electrodes, which are coupled to a body surface of a living subject at different, respective positions in proximity to a region of interest within the body. A switched impedance network applies varying loads to the electrodes. A processor is coupled to receive and measure electrical signals from the electrodes as a function of the varying loads, and to analyze the measured signals so as to compute a local electrical characteristic of one or more locations within the region of interest.Type: GrantFiled: March 4, 2019Date of Patent: December 19, 2023Assignees: The Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Ramot at Tel Aviv University Ltd.Inventors: Mordekhay Medvedovsky, Tomer Gazit, Talma Hendler, Evgeny Tsizin-Goldman, Alex Bronstein
-
Patent number: 11779565Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.Type: GrantFiled: July 22, 2021Date of Patent: October 10, 2023Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Arnon Karni, Karin Bernadet Fainberg
-
Patent number: 11730585Abstract: Repair devices and methods allow better contact between two tissues, such as tendon and bone for better healing process. The repair device is used for re-attaching and securing a torn tissue in place or realigning torn edges back together, or connecting any two tissues. The device includes a tissue attachment, a clamp and a binder and/or an anchor.Type: GrantFiled: November 15, 2017Date of Patent: August 22, 2023Assignees: Ramot at Tel-Aviv University Ltd., The Medical Research, Infrastructure, and Health Services Fund of the Tel-Aviv Medical CenterInventors: Roy Gigi, Mickey Scheinowitz, Noaa Reisman, Itzhak Mallayev, Roman Ziv, Sivan Goldin
-
Patent number: 11714089Abstract: A method of diagnosing a cancer or a pre-malignant lesion is disclosed. The method comprising determining a level of expression of CD24 on leukocytes comprised in a biological sample of a subject, wherein a level of CD24 on small leukocytes and not on large leukocytes above a predetermined threshold is indicative of the cancer or the pre-malignant lesion. A method of monitoring efficacy of cancer therapy and a kit for diagnosing a cancer or a pre-malignant lesion are also disclosed.Type: GrantFiled: May 21, 2018Date of Patent: August 1, 2023Assignee: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Nadir Arber, Shiran Shapira, Diana Kazanov
-
Patent number: 11638534Abstract: A method and system are provided for continuous monitoring perfusion of an organ or extremity, and for early detection of progressive partial occlusion of arterial blood supply or venous drainage of tissue. The method and system measure a delay in wave propagation of a blood perfusion wave, which is associated with flow of blood through a blood vessel. The delay is correlated to an amount of obstruction in the blood vessel.Type: GrantFiled: June 26, 2018Date of Patent: May 2, 2023Assignee: The Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Amir Landesberg, Amit Livneh, Yehuda Wolf
-
Patent number: 11547525Abstract: An endotracheal tube cleaning device, including a rod, and a cleaning head coupled to a distal end of the rod, including a low friction-generating surface; and a high friction-generating surface, wherein the low friction-generating surface contacts an inner surface of the endotracheal tube when moved along the tube in a first direction and the high friction-generating surface contacts the inner surface of the endotracheal tube when moved in a second, opposite direction.Type: GrantFiled: June 6, 2019Date of Patent: January 10, 2023Assignees: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., THE MEDICAL RESEARCH INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Amihay Shinfeld, Yoav Paz, Emanuel Mendes, Joseph Feldman
-
Patent number: 11480571Abstract: Provided relates to the field of cytometry, specifically to flow cytometric methods and kits for improved diagnosis, prognosis and monitoring of tumors and other lesions involving immune cell infiltration. Further provided are embodiments of the subject matter which relate to compositions and methods providing high resolution quantitative means for immunophenotyping and immune modeling, and for identification of disease prognostic and therapy predictive biomarkers.Type: GrantFiled: November 30, 2016Date of Patent: October 25, 2022Assignee: The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical CenterInventors: Ilan Volovitz, Merav Lustgarten, Zvi Ram, Netanel Yakov Shapira, Idan Ben Horin, Gil Diamant
-
Publication number: 20220233578Abstract: Compositions and methods of using same for tissue regeneration are provided. Accordingly, there is provided a composition comprising a hyaluronic acid, a laminin polypeptide, an antioxidant and Copolymer 1 at a concentration range of 10-150 microgram/ml. Also provided is a composition comprising a hyaluronic acid, a laminin polypeptide and vitamin E at a concentration range of 0.3-30 mM. Also provided are matrices and hydrogels of the compositions and methods of using same.Type: ApplicationFiled: June 4, 2020Publication date: July 28, 2022Applicants: Ramot at Tel-Aviv University Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Zvi NEVO, Shimon ROCHKIND
-
Publication number: 20220226432Abstract: Deferred treatment of nerve injuries is provided. Accordingly, there is provided a method of deferred treatment of a nerve injury in a subject in need thereof, the method comprising implanting at least 1 week following onset or diagnosis of the nerve injury in the subject a composition comprising a hyaluronic acid, a laminin polypeptide and an antioxidant at or near the nerve injury of the subject.Type: ApplicationFiled: June 4, 2020Publication date: July 21, 2022Applicants: Ramot at Tel-Aviv University Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Zvi NEVO, Shimon ROCHKIND
-
Patent number: 11389082Abstract: There is provided a method, apparatus, computer program product and wearable device for monitoring volumetric change of a lung during a breathing cycle by using an electronic signal. The method comprises: receiving by a receiver an electronic signal transmitted from a transmitter, wherein at least part of a path of the signal contours at least part of a chest wall of the lung; determining by the receiver measurements of an attribute of the signal received at the beginning and the end of a time interval during the breathing cycle; calculating by a processor a change in length of the signal path during the time interval based on the measurements of the attribute of the signal received at the beginning and the end of the time interval; and calculating by the processor a volumetric change during the time interval based on the change in signal path length.Type: GrantFiled: December 21, 2018Date of Patent: July 19, 2022Assignees: MEDICAL RESEARCH INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER, RESMETRIX MEDICAL LTD.Inventors: Mordechay Beyar, Oren Globerman, Zvi Reznic
-
Patent number: 11219636Abstract: Provided are nucleic acid constructs and systems which comprise (i) a first nucleic acid construct encoding a toxin operatively linked to a first promoter and at least one cancer-associated signaling responsive enhancer element; and (ii) a second nucleic acid construct encoding an anti-toxin operatively linked to a second promoter, the second promoter being stronger than the first promoter. Also provided are pharmaceutical compositions comprising same and methods of using same for treating cancer.Type: GrantFiled: May 17, 2016Date of Patent: January 11, 2022Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Nadir Arber, Shiran Shapira, Dina Kazanov
-
Publication number: 20210393582Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.Type: ApplicationFiled: July 22, 2021Publication date: December 23, 2021Applicant: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Arnon KARNI, Karin Bernadet FAINBERG
-
Publication number: 20210290132Abstract: A method for training a subject diagnosed with a stress disorder caused by a trauma, including: selecting a challenge expected to trigger a symptom of the stress disorder in the subject; exposing the subject to the challenge; recording electrical signals generated by the brain of the subject by at least one electrode, in conjunction with the exposing; processing the recorded electrical signals to estimate an activation level of at least one specific brain region; presenting at least one indication of the estimated activation level to the subject; repeating the recording, the processing and the presenting.Type: ApplicationFiled: June 9, 2021Publication date: September 23, 2021Applicant: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Talma HENDLER, Tom FRUCHTMAN-STEINBOK, Avihai COHEN, Gal RAZ
-
Publication number: 20210269860Abstract: A method of assessing whether a candidate subject is suitable for probiotic treatment is disclosed. The method comprises determining a signature of the gut microbiome of the candidate subject, wherein when the signature of the microbiome of the candidate subject is statistically significantly similar to a signature of a gut microbiome of a control subject known to be responsive to probiotic treatment, it is indicative that the subject is suitable for probiotic treatment.Type: ApplicationFiled: July 8, 2019Publication date: September 2, 2021Applicants: Yeda Research and Development Co. Ltd., The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Eran SEGAL, Eran ELINAV, Zamir HALPERN
-
Patent number: 11103479Abstract: This invention provides small organic molecules useful as therapeutics of neurodegenerative diseases. Small organic molecules that act as inhibitors of bone morphogenetic proteins (BMPs) are useful in the treatment of neuroinflammatory disorders, in particular multiple sclerosis.Type: GrantFiled: April 26, 2018Date of Patent: August 31, 2021Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTERInventors: Arnon Karni, Karin Bernadet Fainberg
-
Publication number: 20210259615Abstract: A method for resilience training, including: exposing a healthy human subject to one or more stress-evoking perturbations selected to affect activation of deeply located limbic areas; instructing the healthy human subject to perform in a timed relation to the exposing, at least one activity configured to selectively affect activation of said deeply located limbic areas; recording EEG signals from the healthy human subject during the exposing; analyzing the recorded EEG signals to identify at least one EEG signature indicating an activation level of the deeply located limbic areas; determining an activation level of the deeply located limbic areas based on the identified at least one EEG signature; delivering a human-detectable indication to the healthy human subject according to the determined activation level.Type: ApplicationFiled: May 13, 2021Publication date: August 26, 2021Applicant: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterInventors: Talma HENDLER, Gal RAZ, Nimrod Jackob KEYNAN
-
Patent number: 11065118Abstract: A brace for mounting to an annulus of a cardiac valve, the brace comprising: first and second bottom gripping wings for gripping the annulus; first and second top gripping wings for gripping the annulus; and a support bridge that connects the top wings to the bottom wings; wherein the brace is deformable from a delivery configuration to a deployed configuration and in the delivery configuration the top wings are oriented substantially back to back along an axis and the bottom wings are oriented substantially back to back along the same axis, and in the deployed configuration the first top and bottom gripping wings face each other to grip the annulus between them and the second top and bottom gripping wings face each other to grip the annulus between them.Type: GrantFiled: March 4, 2014Date of Patent: July 20, 2021Assignee: The Medical Research, Infrastructure And Health Services Fund Of the Tel-Aviv Medical CenterInventors: Gad Keren, Allan C. Entis